Related Funds
Funds with similar focus
Fund Name | Location |
15K Angels | - |
Asterisk Ventures | - |
Aurum Land | Central Region, Singapore, Singapore |
Camac Partners | New York, New York, United States |
CGS Holding | - |
Constant Capital | Accra, Ghana, Greater Accra |
Dimensional Fund Advisors | Austin, Texas, United States |
Early Light Ventures | Baltimore, Maryland, United States |
Finnovista | Madrid, Madrid, Spain |
Freestyle Interactive | - |
GenomePrecision | Beijing, Beijing, China |
Huixin Capital | China, Hong Kong, Hong Kong Island |
Hunan Xingxiang Investment | Changsha, China, Jiangsu |
Korea Investment Holdings | Seoul, Seoul-t'ukpyolsi, South Korea |
Lekker Energie | Berlin, Berlin, Germany |
Lumina Datamatics | Minnesota, Plymouth, United States |
OneAngstrom | - |
Topband | China, Guangdong, Shenzhen |
Twins Partners | - |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Pathalys Pharma | $105M | 20 Aug 2024 | Raleigh, North Carolina, United States | ||
Dock Health | $5M | 25 May 2023 | Boston, Massachusetts, United States | ||
Pathalys Pharma | $150M | 18 Jan 2023 | Raleigh, North Carolina, United States | ||
Pathalys Pharma | $11M | 22 Jun 2021 | Raleigh, North Carolina, United States | ||
Heartbeat Health | $20M | 10 May 2021 | New York, New York, United States | ||
Nephrosant | $16M | 16 Mar 2021 | Brisbane, California, United States | ||
ConsejoSano | $17M | 15 Dec 2020 | Los Angeles, California, United States | ||
Wellth | $10M | 06 May 2020 | Los Angeles, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Pathalys Pharma | $105M | 20 Aug 2024 | Raleigh, North Carolina, United States | ||
Dock Health | $5M | 25 May 2023 | Boston, Massachusetts, United States | ||
Pathalys Pharma | $150M | 18 Jan 2023 | Raleigh, North Carolina, United States | ||
Pathalys Pharma | $11M | 22 Jun 2021 | Raleigh, North Carolina, United States | ||
Heartbeat Health | $20M | 10 May 2021 | New York, New York, United States | ||
Nephrosant | $16M | 16 Mar 2021 | Brisbane, California, United States | ||
ConsejoSano | $17M | 15 Dec 2020 | Los Angeles, California, United States | ||
Wellth | $10M | 06 May 2020 | Los Angeles, California, United States |